|
⚲
|
| Keyboard |
| Zeneca Inc
✚
|
|
|---|---|
| CIK # | 0001657583 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001657583] | |
| 4 | [0001657583] | |
| SC 13D | [0001657583] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Zeneca Inc | ZS Pharma Inc | [2015-11-13] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Astrazeneca PLC | |
| Zeneca Inc | |
| PhaseBio Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 2,404,554 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 600,000 | $5.00 | 3,000,000 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 113,891 | $0.12 | 13,667 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 1,664,217 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Sell | 2,734 | $5.00 | 13,670 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series D Preferred Stock · derivative
|
2018-10-22 | Conversion | 740,337 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series C-1 Preferred Stock · derivative
|
2018-10-22 | Option exercise | 113,891 | $0.00 |